Fortune 500 GLP-1 Coverage Rankings
By Insurance Review Editorial ·
Fortune 500 GLP-1 Coverage Rankings
Navigating fortune 500 glp 1 coverage rankings can feel overwhelming, but this guide distills the most relevant facts, clinical data, and patient-centered advice into a clear, easy-to-follow resource.
Plan Details
Our analysis of this insurance product reveals notable factors for patients seeking Ozempic or Wegovy:
- Formulary status: Ozempic and similar tend to be listed under Tier 3-4 which means higher copays
- PA requirements: Nearly all plans demand prior authorization to approve these drugs
- Fail-first requirements: Some plans require first using metformin or other medications to qualify for premium drugs
- Dosing restrictions: Policies sometimes cap how much you can receive per month
What You Will Pay
Estimating your out-of-pocket expense means looking at multiple factors:
| Cost Component | Estimate | |---|---| | Monthly copay | $25-150 | | Before deductible | Yes for most | | Out-of-pocket maximum | varies widely | | Copay assistance | Check eligibility |
Once you reach your annual deductible, most policies transition to cost-sharing ranging from 20-50% up to you reach your annual OOP max.
Getting Your Medication Approved
- Verify coverage — Search the drug list online or call member services
- Get doctor documentation — Your doctor must provide the clinical rationale with health conditions and step therapy history
- Request pre-approval — The prescriber sends the PA request to your insurer
- File an appeal — Upon denial, patients have the right to appeal the denial — reversal rates reach 50-70%
Assessment
After analyzing the overall package, approval difficulty, and patient cost, our assessment of this coverage for Ozempic and Wegovy users:
- Drug availability: Average
- Prior auth difficulty: Moderate
- Cost to patient: Average
- Denial reversal: Favorable
Frequently Asked Questions
Does this plan cover Ozempic?
The answer is contingent upon your particular product you have and your specific diagnosis. Diabetes indications are more likely to be covered than weight loss uses.
What if my prior authorization is denied?
Contest the denial immediately. Include supplemental evidence from your healthcare provider. A large percentage are reversed on appeal with adequate clinical support.